2 Transform Liquid
NDC Package 81403-0001-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

2 Transform (fucus vesiculosus, chelidonium majus, kali phosphoricum, lycopodium clavatum, natrum muriaticum, quercus glandium spiritus, quercus robur, nux vomica, phytolacca decandra, ornithogalum umbellatum, agnus castus, berberis aquifolium, berberis vulgaris, saccharum officinale, solidago virgaurea, calcarea carbonica, carbo vegetabilis, magnesia phosphorica, natrum phosphoricum, sinapis arvensis, flos, ubidecarenonum, graphites, hypophysis suis, placenta totalis suis, hypothalamus (bovine)) liquids is for weight management and inflammation support.This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. This formulation utilizes a liquid delivery system. Marketed by Murphree Chiropractic, this product is identified by NDC 81403-0001.

Identification & Billing

NDC Package Code
81403-0001-1
Package Description
60 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
81403000101

Clinical Specifications

Proprietary Name
2 Transform
Non-Proprietary Name
Fucus Vesiculosus, Chelidonium Majus, Kali Phosphoricum, Lycopodium Clavatum, Natrum Muriaticum, Quercus Glandium Spiritus, Quercus Robur, Nux Vomica, Phytolacca Decandra, Ornithogalum Umbellatum, Agnus Castus, Berberis Aquifolium, Berberis Vulgaris, Saccharum Officinale, Solidago Virgaurea, Calcarea Carbonica, Carbo Vegetabilis, Magnesia Phosphorica, Natrum Phosphoricum, Sinapis Arvensis, Flos, Ubidecarenonum, Graphites, Hypophysis Suis, Placenta Totalis Suis, Hypothalamus (bovine)
Substance Name
Activated Charcoal; Berberis Aquifolium Root Bark; Berberis Vulgaris Root Bark; Bos Taurus Hypothalamus; Chaste Tree Fruit; Chelidonium Majus Whole; Dibasic Potassium Phosphate; Fucus Vesiculosus; Graphite; Lycopodium Clavatum Spore; Magnesium Phosphate, Dibasic Trihydrate; Ornithogalum Umbellatum Whole; Oyster Shell Calcium Carbonate, Crude; Phytolacca Americana Root; Quercus Robur Nut; Quercus Robur Twig Bark; Sinapis Arvensis Flowering/fruiting Top; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate; Solidago Virgaurea Flowering Top; Strychnos Nux-vomica Seed; Sucrose; Sus Scrofa Pituitary Gland; Sus Scrofa Placenta; Ubidecarenone
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
For weight management and inflammation support.This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective. For weight management and inflammation support.This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Regulatory & Marketing

Labeler Name
Murphree Chiropractic
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
06-28-2021
End Marketing Date
08-12-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81403-0001-1 identifies a specific commercial package of 60 ml in 1 bottle, dropper of 2 Transform, a human over the counter drug labeled by Murphree Chiropractic. This liquid is formulated for oral use and contains activated charcoal; berberis aquifolium root bark; berberis vulgaris root bark; bos taurus hypothalamus; chaste tree fruit; chelidonium majus whole; dibasic potassium phosphate; fucus vesiculosus; graphite; lycopodium clavatum spore; magnesium phosphate, dibasic trihydrate; ornithogalum umbellatum whole; oyster shell calcium carbonate, crude; phytolacca americana root; quercus robur nut; quercus robur twig bark; sinapis arvensis flowering/fruiting top; sodium chloride; sodium phosphate, dibasic, heptahydrate; solidago virgaurea flowering top; strychnos nux-vomica seed; sucrose; sus scrofa pituitary gland; sus scrofa placenta; ubidecarenone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Murphree Chiropractic on June 28, 2021.

How is this Murphree Chiropractic product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81403000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
81403-0001-1
11-Digit CMS (5-4-2)
81403-0001-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.